FR2841156B1 - Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant - Google Patents
Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenantInfo
- Publication number
- FR2841156B1 FR2841156B1 FR0207545A FR0207545A FR2841156B1 FR 2841156 B1 FR2841156 B1 FR 2841156B1 FR 0207545 A FR0207545 A FR 0207545A FR 0207545 A FR0207545 A FR 0207545A FR 2841156 B1 FR2841156 B1 FR 2841156B1
- Authority
- FR
- France
- Prior art keywords
- particles
- conjugates
- diagnostic
- therapeutic
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0207545A FR2841156B1 (fr) | 2002-06-19 | 2002-06-19 | Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant |
PCT/FR2003/001884 WO2004001414A1 (fr) | 2002-06-19 | 2003-06-19 | Nanoparticules magnetiques fluorescentes |
AU2003260611A AU2003260611A1 (en) | 2002-06-19 | 2003-06-19 | Fluorescent magnetic nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0207545A FR2841156B1 (fr) | 2002-06-19 | 2002-06-19 | Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2841156A1 FR2841156A1 (fr) | 2003-12-26 |
FR2841156B1 true FR2841156B1 (fr) | 2004-09-10 |
Family
ID=29719860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0207545A Expired - Fee Related FR2841156B1 (fr) | 2002-06-19 | 2002-06-19 | Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003260611A1 (fr) |
FR (1) | FR2841156B1 (fr) |
WO (1) | WO2004001414A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1312479C (zh) | 2003-08-08 | 2007-04-25 | 清华大学 | 一种纳米荧光磁粒及其制备方法 |
EP1718341A2 (fr) * | 2004-01-20 | 2006-11-08 | Alnis Biosciences, Inc. | Articles comprenant un materiau magnetique et des agents bioactifs |
ES2605480T3 (es) * | 2008-12-21 | 2017-03-14 | Consiglio Nazionale Delle Ricerche | Sistema de liberación de fármacos a base de eritrocitos, método de preparación y sus usos |
JP5317899B2 (ja) * | 2009-09-11 | 2013-10-16 | 富士フイルム株式会社 | ラテックス粒子を用いた免疫アッセイ方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU634631B2 (en) * | 1989-12-14 | 1993-02-25 | Dade International Inc. | Magnetically responsive fluorescent polymer particles and application thereof |
WO1998008094A1 (fr) * | 1996-08-23 | 1998-02-26 | Amcell Corporation | Detection sensible de marqueurs de surface de cellules sur des cellules viables |
WO1999062079A1 (fr) * | 1998-05-26 | 1999-12-02 | Bar-Ilan University | Nucleation et croissance de nanoparticules d'oxyde metallique magnetique et utilisation de ces dernieres |
JP2002535656A (ja) * | 1999-01-23 | 2002-10-22 | ミナーヴァ・バイオテクノロジーズ・コーポレーション | コロイド固定化種と非コロイド構造上の種との相互作用 |
US6660379B1 (en) * | 1999-02-05 | 2003-12-09 | University Of Maryland, Baltimore | Luminescence spectral properties of CdS nanoparticles |
WO2001073117A1 (fr) * | 2000-03-31 | 2001-10-04 | MEMOREC STOFFEL GmbH - MEDIZINISCH-MOLEKULARE ENTWICKLUNG, KÖLN | Utilisation de particules, aptes a transmettre des signaux et possedant au moins un groupe d'affinite pour les acides nucleiques marques |
US6773812B2 (en) * | 2000-04-06 | 2004-08-10 | Luminex Corporation | Magnetically-responsive microspheres |
US7892854B2 (en) * | 2000-06-21 | 2011-02-22 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
EP1362121A2 (fr) * | 2000-08-11 | 2003-11-19 | Nanosphere, Inc. | Nanoparticules comportant des oligonucleotides fixes dessus et utilisations associees |
-
2002
- 2002-06-19 FR FR0207545A patent/FR2841156B1/fr not_active Expired - Fee Related
-
2003
- 2003-06-19 WO PCT/FR2003/001884 patent/WO2004001414A1/fr not_active Application Discontinuation
- 2003-06-19 AU AU2003260611A patent/AU2003260611A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2841156A1 (fr) | 2003-12-26 |
WO2004001414A1 (fr) | 2003-12-31 |
AU2003260611A1 (en) | 2004-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2182006A3 (fr) | Compositions et procédés pour le traitement de maladies liées au système immunitaire | |
EP2322203A3 (fr) | Les compositions et les methodes pour le traitement de maladies liees immunisees | |
DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
MXPA04002593A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
MXPA03011985A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
SE0301700D0 (sv) | Novel compounds | |
ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
AU2002324914A1 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
MXPA04000062A (es) | Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia. | |
WO2003088808A3 (fr) | Compositions et methodes permettant de diagnostiquer et de traiter une tumeur | |
BR9914044A (pt) | ésteres tetrahidropirido | |
IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
SE0301653D0 (sv) | Novel compounds | |
UA87335C2 (en) | Gel composition of 4-hydroxytamoxifen | |
DE60219005D1 (de) | Feste pharmazeutische formulierung enthaltend modafinil | |
WO2006110760A3 (fr) | Compositions et methodes de diagnostic et de traitement de tumeur | |
IL164217A0 (en) | Pharmaceutical compositions containing water-soluble propofol and methods of administering same | |
DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
ATE355288T1 (de) | Verbindungen und therapeutische methoden | |
WO2004067564A3 (fr) | Compositions contre l'antgene cancereux liv-1 et leurs utilisations | |
FR2841156B1 (fr) | Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant | |
WO2004096124A3 (fr) | Compositions et procedes pour le diagnostic et le traitement de tumeurs | |
WO2004024077A3 (fr) | Nouvelle composition et nouveaux procedes pour le traitement du psoriasis | |
MY134019A (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
BR0111785A (pt) | Composições e métodos para tratamento de candidìase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20060228 |